Abstract
Mitral valve prolapse (MVP) is one of the most common forms of valvular heart disease. The clinical presentation can be very diverse, ranging from an incidental finding within asymptomatic patients to dramatic cases with severe mitral regurgitation, heart failure, bacterial endocarditis, or even sudden cardiac death. Mitral valve prolapse appears to be one of the most common Mendelian cardiovascular abnormalities in humans. This chapter briefly discusses the epidemiologic aspects of mitral valve prolapse, its pathophysiology, and the current status of genetic knowledge of this intriguing valvular disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barlow JB, Bosman CK. Aneurysmal protrusion of the posterior leaflet of the mitral valve. An auscultatory-electrocardiographic syndrome. Am Heart J. 1966;71:166-178.
Weisse AB. Mitral valve prolapse: now you see it; now you don’t: recalling the discovery, rise and decline of a diagnosis. Am J Cardiol. 2007;99:129-133.
Hepner AD, Ahmadi-Kashani M, Movahed MR. The prevalence of mitral valve prolapse in patients undergoing echocardiography for clinical reason. Int J Cardiol. 2007;123:55-57.
Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med. 1999;341:1-7.
Hayek E, Gring CN, Griffin BP. Mitral valve prolapse. Lancet. 2005;365:507-518.
Grau JB, Pirelli L, Yu PJ, et al. The genetics of mitral valve prolapse. Clin Genet. 2007;72:288-295.
Nishimura RA, McGoon MD, Shub C, et al. Echocardiographically documented mitral-valve prolapse. Long-term follow-up of 237 patients. N Engl J Med. 1985;313:1305-1309.
Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736-1754.
Bonow RO, Carabello BA, Chatterjee K, et al. Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118:e523-e661.
Kligfield P, Levy D, Devereux RB, et al. Arrhythmias and sudden death in mitral valve prolapse. Am Heart J. 1987;113:1298-1307.
Basso C, Corrado D, Thiene G. Cardiovascular causes of sudden death in young individuals including athletes. Cardiol Rev. 1999;7:127-135.
Devereux RB, Brown WT, Kramer-Fox R, et al. Inheritance of mitral valve prolapse: effect of age and sex on gene expression. Ann Intern Med. 1982;97:826-832.
Strahan NV, Murphy EA, Fortuin NJ, et al. Inheritance of the mitral valve prolapse syndrome. Discussion of a three-dimensional penetrance model. Am J Med. 1983;74:967-972.
Weiss AN, Mimbs JW, Ludbrook PA, et al. Echocardiographic detection of mitral valve prolapse. Exclusion of false positive diagnosis and determination of inheritance. Circulation. 1975;52:1091-1096.
Disse S, Abergel E, Berrebi A, et al. Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet. 1999;65:1242-1251.
Freed LA, Acierno JS Jr, Dai D, et al. A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet. 2003;72:1551-1559.
Nesta F, Leyne M, Yosefy C, et al. New locus for autosomal dominant mitral valve prolapse on chromosome 13: clinical insights from genetic studies. Circulation. 2005;112:2022-2030.
Kyndt F, Gueffet JP, Probst V, et al. Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. Circulation. 2007;115:40-49.
Sasaki A, Masuda Y, Ohta Y, et al. Filamin associates with Smads and regulates transforming growth factor-beta signaling. J Biol Chem. 2001;276:17871-17877.
Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425:577-584.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag London Limited
About this chapter
Cite this chapter
van Haelst, P.L., Oomen, T., van Tintelen, J.P. (2011). The Genetics of Mitral Valve Prolapse. In: Baars, H., Doevendans, P., van der Smagt, J. (eds) Clinical Cardiogenetics. Springer, London. https://doi.org/10.1007/978-1-84996-471-5_15
Download citation
DOI: https://doi.org/10.1007/978-1-84996-471-5_15
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84996-470-8
Online ISBN: 978-1-84996-471-5
eBook Packages: MedicineMedicine (R0)